| Profiles RNS

Profile

MD, Albert Einstein College of Medicine
MPH, Columbia University

Websites

Boston Medical Center Physician Provider Profile

Research
Publications

BU Research
BMC Research

Multicenter, Randomized, Open Label, Parallel-Group Study to Evaluate User Satisfaction, Acceptability, and Tolerability of the Ultra Low Dose Levonorgestrel Intrauterine Contraceptive System with 12u
01/15/2011 - 12/31/2015 (PI)
Bayer Schering Pharma AG (Germany)

Multi-center, Open-label, Randomized Study to Assess the Safety and Contraceptive Efficacy of Two Doses (In Vitro 12pg/24 h) of the Ultra Low Dose Levonorges
12/01/2007 - 12/31/2013 (PI)
Bayer AG

Multicenter, open-label, uncontrolled study to investigate the efficacy and safety of the transdermal contraceptive patch containing 0.55 mg ethinyl estradiol and 2.1 mg gestodene (material no. 8
05/01/2009 - 12/31/2011 (PI)
Bayer AG

Mifepristone vs Misoprostol for Cervical Preparation Prior to Surgical Abortion between 11 & 15 week
06/01/2012 - 06/30/2015 (PI)
Society of Family Planning

Mifepristone vs. Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion
07/01/2011 - 09/30/2014 (PI)
Society of Family Planning

Cervical preparation before dilation and evacuation at 16-24 weeks gestation: A multicenter randomiz
03/22/2013 - 12/31/2013 (PI)
Society of Family Planning

Mifepristone versus laminaria for cervical preparation prior to surgical abortion at 14-16 weeks
10/01/2009 - 10/01/2011 (PI)
Society of Family Planning

Misoprostol for treatment of fetal death at 14-18 weeks of pregnancy, inclusive, not accompanied by
11/01/2008 - 10/31/2009 (PI)
Gynuity Health Projects, LLC

Title

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Mark AG, Edelman A, Borgatta L. Second-trimester postabortion care for ruptured membranes, fetal demise, and incomplete abortion. Int J Gynaecol Obstet. 2015 May; 129(2):98-103. PMID: 25660084; DOI: 10.1016/j.ijgo.2014.11.011;

Sonalkar S, McClusky J, Hou MY, Borgatta L. Administration of depot medroxyprogesterone acetate on the day of mifepristone for medical abortion: a pilot study. Contraception. 2015 Feb; 91(2):174-7. PMID: 25481376; DOI: 10.1016/j.contraception.2014.10.010;

Paris AE, Sonalkar S, Kattan D, McClusky J, Vragovic O, Borgatta L. Mifepristone and misoprostol compared with osmotic dilator insertion before surgical abortion at 15-18 weeks. Obstet Gynecol. 2014 May; 123 Suppl 1:5S.View Related Profiles.

Paris, Amy
Borgatta, Lynn
Vragovic, Olivera

PMID: 24770232; DOI: 10.1097/01.AOG.0000447250.38819.1f;

Sonalkar S, Hou MY, Hou M, Borgatta L. Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: a pilot study. Contraception. 2013 Nov; 88(5):671-3.View Related Profiles.

Borgatta, Lynn
Sonalkar, Sarita

PMID: 24028749; DOI: 10.1016/j.contraception.2013.07.008;

Mark A, Sonalkar S, Borgatta L. One-year continuation of the etonogestrel contraceptive implant in women with postabortion or interval placement. Contraception. 2013 Nov; 88(5):619-23.View Related Profiles.

Borgatta, Lynn
Sonalkar, Sarita

PMID: 23790436; DOI: 10.1016/j.contraception.2013.05.009;

Greenstein Y, Shah AJ, Vragovic O, Cabral H, Soto-Wright V, Borgatta L, Kuohung W. Tuboovarian abscess. Factors associated with operative intervention after failed antibiotic therapy. J Reprod Med. 2013 Mar-Apr; 58(3-4):101-6.View Related Profiles.

Cabral, Howard
Borgatta, Lynn
Vragovic, Olivera
Soto-Wright, Valena
Kuohung, Wendy

PMID: 23539877

Borgatta L, Mark A. Response to letter to the editor. Contraception. 2013 Apr; 87(4):508. PMID: 23218861; DOI: 10.1016/j.contraception.2012.10.036;

Roncari D, Politch JA, Sonalkar S, Finneseth M, Borgatta L. Inflammation or infection at the time of second trimester induced abortion. Contraception. 2013 Jan; 87(1):67-70.View Related Profiles.

Politch, Joseph
Borgatta, Lynn
Finneseth, Molly
Sonalkar, Sarita

PMID: 23102591; DOI: 10.1016/j.contraception.2012.09.016;

Borgatta L, Roncari D, Sonalkar S, Mark A, Hou MY, Finneseth M, Vragovic O. Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial. Contraception. 2012 Nov; 86(5):567-71.View Related Profiles.

Borgatta, Lynn
Finneseth, Molly
Vragovic, Olivera
Sonalkar, Sarita

PMID: 22682721; DOI: 10.1016/j.contraception.2012.05.002;

Borgatta L, Kapp N. Clinical guidelines. Labor induction abortion in the second trimester. Contraception. 2011 Jul; 84(1):4-18. PMID: 21664506; DOI: 10.1016/j.contraception.2011.02.005;

Showing 10 of 58 results. Show More

Betstadt SJ, Turok DK, Kapp N, Feng KT, Borgatta L. Intrauterine device insertion after medical abortion. Contraception. 2011 Jun; 83(6):517-21. PMID: 21570548; DOI: 10.1016/j.contraception.2010.10.006;

Ellis SC, Kapp N, Vragpvoc O, Borgata L. Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion. Contraception. 2010 May; 81(5):441-5.View Related Profiles.

Borgatta, Lynn
Carr-Ellis, Sacheen

PMID: 20399952; DOI: 10.1016/j.contraception.2009.12.018;

Borgatta L, Betstadt SJ, Reed A, Feng KT. Relationship of intraamniotic digoxin to fetal demise. Contraception. 2010 Apr; 81(4):328-30. PMID: 20227550; DOI: 10.1016/j.contraception.2009.12.001;

Moreno-Ruiz NL, Vesona JL, Betstadt SJ, Feng KT, Borgatta L. Misoprostol priming prior to second trimester medical abortion. Int J Gynaecol Obstet. 2009 Jul; 106(1):67-8. PMID: 19358989; DOI: 10.1016/j.ijgo.2009.03.005;

Borgatta L, Sayegh R, Betstadt SJ, Stubblefield PG. Cervical obstruction complicating second-trimester abortion: treatment with misoprostol. Obstet Gynecol. 2009 Feb; 113(2 Pt 2):548-50.View Related Profiles.

Borgatta, Lynn
Stubblefield, Phillip

PMID: 19155952; DOI: 10.1097/AOG.0b013e318193bca7;

Strafford MA, Mottl-Santiago J, Savla A, Soodoo N, Borgatta L. Relationship of obesity to outcome of medical abortion. Am J Obstet Gynecol. 2009 May; 200(5):e34-6.View Related Profiles.

Mottl-Santiago, Julie
Borgatta, Lynn

PMID: 19110221; DOI: 10.1016/j.ajog.2008.10.016;

Creinin MD, Meyn LA, Borgatta L, Barnhart K, Jensen J, Burke AE, Westhoff C, Gilliam M, Dutton C, Ballagh SA. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstet Gynecol. 2008 Feb; 111(2 Pt 1):267-77. PMID: 18238962; DOI: 10.1097/01.AOG.0000298338.58511.d1;

Kapp N, Borgatta L, Stubblefield P, Vragovic O, Moreno N. Mifepristone in second-trimester medical abortion: a randomized controlled trial. Obstet Gynecol. 2007 Dec; 110(6):1304-10.View Related Profiles.

Borgatta, Lynn
Vragovic, Olivera
Stubblefield, Phillip

PMID: 18055725

Kapp N, Curtis KM, Borgatta L. Study design to evaluate the safety and effectiveness of hormonal contraception for women. Clin Obstet Gynecol. 2007 Dec; 50(4):850-67. PMID: 17982328

Green J, Borgatta L, Sia M, Kapp N, Saia K, Carr-Ellis S, Vragovic O. Intervention rates for placental removal following induction abortion with misoprostol. Contraception. 2007 Oct; 76(4):310-3.View Related Profiles.

Saia, Kelley
Borgatta, Lynn
Sia, Michelle
Vragovic, Olivera
Carr-Ellis, Sacheen

PMID: 17900443

Jeong YJ, Borgatta L, Kapp N, Peter I, Bianchi DW, Johnson KL. Short-term clearance of cell-free nucleic acids after first-trimester termination of pregnancy. Fertil Steril. 2007 Sep; 88(3):730-3. PMID: 17481618

Moreno-Ruiz NL, Borgatta L, Yanow S, Kapp N, Wiebe ER, Winikoff B. Alternatives to mifepristone for early medical abortion. Int J Gynaecol Obstet. 2007 Mar; 96(3):212-8. PMID: 17280669

Kapp N, Borgatta L, Ellis SC, Stubblefield P. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion. Contraception. 2006 May; 73(5):525-7.View Related Profiles.

Borgatta, Lynn
Stubblefield, Phillip

PMID: 16627039

Chen AY, Mottl-Santiago J, Vragovic O, Wasserman S, Borgatta L. Bleeding after medication-induced termination of pregnancy with two dosing schedules of mifepristone and misoprostol. Contraception. 2006 Apr; 73(4):415-9.View Related Profiles.

Mottl-Santiago, Julie
Borgatta, Lynn
Vragovic, Olivera

PMID: 16531178

Borgatta L, Chen AY, Vragovic O, Stubblefield PG, Magloire CA. A randomized clinical trial of the addition of laminaria to misoprostol and hypertonic saline for second-trimester induction abortion. Contraception. 2005 Nov; 72(5):358-61.View Related Profiles.

Borgatta, Lynn
Vragovic, Olivera
Stubblefield, Phillip

PMID: 16246662

Wataganara T, Chen AY, LeShane ES, Sullivan LM, Borgatta L, Bianchi DW, Johnson KL. Changes of cell-free fetal DNA in maternal plasma after elective termination of pregnancy. Clin Chem. 2005 Jan; 51(1):217-9.View Related Profiles.

Sullivan, Lisa
Borgatta, Lynn

PMID: 15528293

Wataganara T, Peter I, Messerlian GM, Borgatta L, Bianchi DW. Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels. Obstet Gynecol. 2004 Sep; 104(3):545-50. PMID: 15339767

Borgatta L, Mullally B, Vragovic O, Gittinger E, Chen A. Misoprostol as the primary agent for medical abortion in a low-income urban setting. Contraception. 2004 Aug; 70(2):121-6.View Related Profiles.

Gittinger, Elizabeth
Borgatta, Lynn
Vragovic, Olivera

PMID: 15288216

Stubblefield PG, Carr-Ellis S, Borgatta L. Methods for induced abortion. Obstet Gynecol. 2004 Jul; 104(1):174-85.View Related Profiles.

Borgatta, Lynn
Stubblefield, Phillip
Carr-Ellis, Sacheen

PMID: 15229018

Wataganara T, Leshane ES, Chen AY, Sullivan LM, Peter I, Borgatta L, Johnson KL, Bianchi DW. Circulating cell-free fetal nucleic acid analysis may be a novel marker of fetomaternal hemorrhage after elective first-trimester termination of pregnancy. Ann N Y Acad Sci. 2004 Jun; 1022:129-34.View Related Profiles.

Sullivan, Lisa
Borgatta, Lynn

PMID: 15251951

Wataganara T, LeShane ES, Chen AY, Borgatta L, Peter I, Johnson KL, Bianchi DW. Plasma gamma-globin gene expression suggests that fetal hematopoietic cells contribute to the pool of circulating cell-free fetal nucleic acids during pregnancy. Clin Chem. 2004 Apr; 50(4):689-93. PMID: 15044329

Wataganara T, Chen AY, LeShane ES, Sullivan LM, Borgatta L, Bianchi DW, Johnson KL. Cell-free fetal DNA levels in maternal plasma after elective first-trimester termination of pregnancy. Fertil Steril. 2004 Mar; 81(3):638-44.View Related Profiles.

Sullivan, Lisa
Borgatta, Lynn

PMID: 15037414

Borgatta L, Murthy A, Chuang C, Beardsley L, Burnhill MS. Pregnancies diagnosed during Depo-Provera use. Contraception. 2002 Sep; 66(3):169-72. PMID: 12384205

Borgatta L, Chen AY, Reid SK, Stubblefield PG, Christensen DD, Rashbaum WK. Pelvic embolization for treatment of hemorrhage related to spontaneous and induced abortion. Am J Obstet Gynecol. 2001 Sep; 185(3):530-6.View Related Profiles.

Borgatta, Lynn
Stubblefield, Phillip

PMID: 11568773

Borgatta L, French A, Vragovic O, Burnhill MS. Early medical abortion with methotrexate and misoprostol: outcomes and satisfaction among women aged 15-21 years. J Pediatr Adolesc Gynecol. 2001 Feb; 14(1):9-16.View Related Profiles.

Borgatta, Lynn
Vragovic, Olivera

PMID: 11358701

Borgatta L, Burnhill MS, Tyson J, Leonhardt KK, Hausknecht RU, Haskell S. Early medical abortion with methotrexate and misoprostol. Obstet Gynecol. 2001 Jan; 97(1):11-6. PMID: 11152899

Kuohung W, Borgatta L, Larrieux JR, Weiss RM. Pelvic tuberculosis diagnosed by hysteroscopy during infertility evaluation. J Assist Reprod Genet. 2000 Sep; 17(8):459-60.View Related Profiles.

Larrieux, Jean-Robert
Borgatta, Lynn
Kuohung, Wendy

PMID: 11062859; PMCID: PMC3455572

Borgatta L, French A, Vragovic O, Burnhill M. Early medical abortion with methotrexate. Outcome and satisfaction among women aged 15-20 years J Pediatr Adolesc Gynecol. 2000 May; 13(2):87-8. PMID: 10869971

Kuohung W, Borgatta L, Stubblefield P. Low-dose oral contraceptives and bone mineral density: an evidence-based analysis. Contraception. 2000 Feb; 61(2):77-82.View Related Profiles.

Borgatta, Lynn
Stubblefield, Phillip
Kuohung, Wendy

PMID: 10802271

Borgatta L, Burnhill M, Haskell S, Nichols M, Leonhardt K. Instituting medical abortion services: changes in outcome and acceptability related to provider experience. J Am Med Womens Assoc. 2000; 55(3 Suppl):173-6. PMID: 10846332

Wright TC, Lorincz A, Ferris DG, Richart RM, Ferenczy A, Mielzynska I, Borgatta L. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol. 1998 May; 178(5):962-6. PMID: 9609567

Borgatta L, Burnhill M, Stubblefield P. Single dose methotrexate therapy: application to interstitial ectopic pregnancy. Int J Gynaecol Obstet. 1998 Mar; 60(3):279-82.View Related Profiles.

Borgatta, Lynn
Stubblefield, Phillip

PMID: 9544713

Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy? J Fam Pract. 1998 Feb; 46(2):125-34. PMID: 9487318

Borgatta L. Managing clinical complexities of long-term contraception. Medscape Womens Health. 1998 Jan; 3(1):3. PMID: 9732086

Borgatta L. Mechanism of intrauterine device contraceptive action. Am J Obstet Gynecol. 1997 Oct; 177(4):976-7. PMID: 9369856

Borgatta L, Lopatinsky I, Shaw FM. Overcoming unsatisfactory colposcopy. Use of osmotic dilators. J Reprod Med. 1997 May; 42(5):271-5. PMID: 9172116

Borgatta L, Nickinovich D. Pain during early abortion. J Reprod Med. 1997 May; 42(5):287-93. PMID: 9172119

Borgatta L, Jenny RW, Gruss L, Ong C, Barad D. Clinical significance of methohexital, meperidine, and diazepam in breast milk. J Clin Pharmacol. 1997 Mar; 37(3):186-92. PMID: 9089420

Borgatta L. Sexually transmitted diseases. Ann N Y Acad Sci. 1994 Dec 30; 736:102-13. PMID: 7710196

Borgatta L, Barad D. Prolonged retention of laminaria fragments: an unusual complication of laminaria usage. Obstet Gynecol. 1991 Nov; 78(5 Pt 2):988-90. PMID: 1923249

Borgatta L, Watras J, Katz AM, Ehrlich BE. Regional differences in calcium-release channels from heart. Proc Natl Acad Sci U S A. 1991 Mar 15; 88(6):2486-9. PMID: 1706525; PMCID: PMC51257

Ondrias K, Borgatta L, Kim DH, Ehrlich BE. Biphasic effects of doxorubicin on the calcium release channel from sarcoplasmic reticulum of cardiac muscle. Circ Res. 1990 Nov; 67(5):1167-74. PMID: 2171802

Borgatta L, Gruss L, Barad D, Kaali SG. Direct trocar insertion vs. Verres needle use for laparoscopic sterilization. J Reprod Med. 1990 Sep; 35(9):891-4. PMID: 2146389

Borgatta L, Piening SL, Cohen WR. Association of episiotomy and delivery position with deep perineal laceration during spontaneous delivery in nulliparous women. Am J Obstet Gynecol. 1989 Feb; 160(2):294-7. PMID: 2916609

Borgatta L, Fisher M, Robbins N. Hand protection and protection from hands: hand-washing, germicides and gloves. Women Health. 1989; 15(4):77-92. PMID: 2515660

Borgatta L, Shrout PE, Divon MY. Reliability and reproducibility of nonstress test readings. Am J Obstet Gynecol. 1988 Sep; 159(3):554-8. PMID: 3421253

Borgatta L. Management of breech second twin. Am J Obstet Gynecol. 1984 Jan 1; 148(1):120-1. PMID: 6691376

Borgatta L. Sensitivity to deodorant sanitary pads. JAMA. 1978 Sep 15; 240(12):1239-40. PMID: 682302

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Contact for Mentoring: